chr1-100723190-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001078.4(VCAM1):āc.511A>Gā(p.Lys171Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001078.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VCAM1 | NM_001078.4 | c.511A>G | p.Lys171Glu | missense_variant | 3/9 | ENST00000294728.7 | |
VCAM1 | NM_001199834.2 | c.325A>G | p.Lys109Glu | missense_variant | 3/9 | ||
VCAM1 | NM_080682.3 | c.511A>G | p.Lys171Glu | missense_variant | 3/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VCAM1 | ENST00000294728.7 | c.511A>G | p.Lys171Glu | missense_variant | 3/9 | 1 | NM_001078.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152044Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250616Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135422
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460990Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726798
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 16, 2021 | The c.511A>G (p.K171E) alteration is located in exon 3 (coding exon 3) of the VCAM1 gene. This alteration results from a A to G substitution at nucleotide position 511, causing the lysine (K) at amino acid position 171 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at